€
B. Monch et al. / Journal of Molecular Structure 1105 (2016) 389e395
390
inaccuracies in measurements caused by residual template
bleeding.
C
35H41N5O5 ꢁ H2O (%): C, 66.75; H, 6.88; N, 11.12; found: C, 66.22;
H, 6.85; N, 10.91. HR-MS: calc. for C35H42N5Oþ5 612.3181; found
A feasibly and reasonably priced template for the synthesis of
MIPs for EAs is Dihydroergocristine (DHEC), which can be obtained
from commercial available Dihydroergocristine mesylate (DHEC
mesylate, Fig. 1). To form suitable receptor or catalytically active
sites for EAs during the imprinting process it is essential that DHEC
possess the same configuration of the asymmetric centres as the
EAs. Since it is not known in detail whether the configurations of
the asymmetric centres are influenced during the synthesis steps, it
is necessary to identify the absolute configuration of DHEC, based
on single crystal X-ray data. Furthermore, only if the conformation
of the DHEC reveals a high degree of shape similarity with those of
the EAs a selective interaction between the MIP and the EAs can be
ensured. Otherwise during imprinting of the polymer an arrange-
ment of potential binding sites would be generated which is not
suitable for the EAs. Therefore it is necessary to verify the shape
similarity under the influence of different solvents used for the
synthesis. A reliable possibility to prove this requirement approx-
imately is based on the single crystal X-ray analysis. For answering
these two questions the crystal structures of DHEC crystallized
from different solvents were determined. Here we present
the crystal structure of four different solvatomorphs of DHEC, the
conformational relation among these structures, and prove the
suitability of DHEC as a template for EAs for MIPs.
612.3180 [M þ Hþ]. 1H NMR (600 MHz, CD3OD, ppm)
d: 7.37e7.34
(m, 2H, H-180/220), 7.22e7.18 (m, 2H, H-190/210), 7.15 (dt, J ¼ 8.2,
0.7 Hz, 1H, H-14), 7.14e7.10 (m, 1H, H-200), 7.09 (dd, J ¼ 8.1, 7.1 Hz,
1H, H-13), 6.91 (d, J ¼ 1.5 Hz, 1H, H-2), 6.86 (ddd, J ¼ 7.3, 1.4, 0.6 Hz,
1H, H-12), 4.68 (t, J ¼ 5.8 Hz, 1H, H-50), 3.83 (dd, J ¼ 9.2, 6.8 Hz, 1H,
H-110), 3.59e3.52 (m, 1H, H-80A), 3.52e3.47 (m, 1HH-80B), 3.44 (dd,
J ¼ 14.6, 4.3 Hz, 1H, H-4A), 3.33 (dd, J ¼ 14.1, 6.1 Hz, 1H, H-160A), 3.21
(dd, J ¼ 14.0, 5.5 Hz, 1H, H-160B), 3.04 (ddd, J ¼ 11.5, 3.8, 2.0 Hz, 1H,
H-7A), 2.97e2.90 (m, 1H, H-10), 2.93e2.87 (m, 1H, H-8), 2.84e2.76
(m, 1H, H-9A), 2.64 (ddd, J ¼ 14.6, 11.1, 1.8 Hz, 1H, H-4B), 2.49 (s, 3H,
H-17), 2.46 (t, J ¼ 11.6 Hz, 1H, H-7B), 2.20 (ddd, J ¼ 11.2, 9.9,4.3 Hz,
1H, H-5) 2.16e2.12 (m, 1H, H-130), 2.13 (dd, J ¼ 13.6, 6.8 Hz, 1H, H-
100A), 2.12e2.08 (m, 1H, H-100B), 2.07e1.99 (m, 1H, H-90A), 1.92e1.80
(m, 1H, H-90B), 1.61 (q, J ¼ 12.5 Hz, 1H, H-9B), 1.12 (d, J ¼ 6.7 Hz, 3H,
H-140/150), 0.96 (d, J ¼ 6.8 Hz, 3H, H-140/150). 13C NMR (151 MHz,
CD3OD, ppm) d
: 178.2 (C-18), 167.9 (C-30), 167.2 (C-60), 139.9 (C-170),
135.1 (C-15), 132.8 (C-11), 131.0 (C-180/C-220), 129.0 (C-190/C-210),
127.3 (C-200), 127.3 (C-16), 123.5 (C-13), 119.4 (C-2), 113.5 (C-12),
111.2 (C-3), 109.9 (C-14), 105.1 (C-120), 92.2 (C-20), 68.4 (C-5), 65.3
(C-110), 59.8 (C-7), 58.2 (C-50), 47.4 (C-80), 43.3 (C-8), 43.2 (C-17),
40.9 (C-10), 40.3 (C-160), 35.1 (C130), 32.4 (C-9), 27.7 (C-4), 27.3 (C-
100), 23.1 (C-90), 17.2 (C-140/150), 16.1 (C-140/C-150). IR (microscope,
cmꢂ1): 3620, 3425, 3339, 2945, 2806, 1710, 1668, 1643, 1632, 1533,
1443, 1225, 1209, 1036, 1015.
2. Experimental
2.2. Crystallization of dihydroergocristine
2.1. Synthesis of dihydroergocristine
Dihydroergocristine was crystallized from various solvents
(methanol, chloroform, dichloromethane, acetonitrile), for details
see Table 1. Colourless crystals suitable for X-ray analysis were
formed after several weeks on slow evaporation of the solvent at
ambient temperature in the absence of light.
20.3 g (28.7 mmol) Dihydroergocristine mesylate (Teva Czech
ꢀ
Industries s.r.o., Opava, Komarov, Czech Republic) were suspended
in 200 mL of a 25% ammonia solution (p. A., Merck KGaA, Darm-
stadt, Germany). Then 1000 mL chloroform (p. A., neoLab Migge
Laborbedarf-Vertriebs GmbH, Heidelberg, Germany) were added
and the suspension was stirred at ambient temperature until the
solid was dissolved. After phase separation the aqueous layer was
extracted twice with chloroform (1000 mL each). The combined
organic layers were washed with 1000 mL brine, subsequently
dried over Na2SO4 (p. A., Merck KGaA), filtered and evaporated to
dryness. The resulting white product was further dried 4 days at
50 ꢀC in vacuo. Codestillation with acetone (CHEMSOLUTE®, Th.
Geyer GmbH & Co. KG, Renningen, Germany) and water (Seralpure)
was performed to remove small amounts of remaining solvent.
Subsequently, the powder was dried again in vacuo for 2 days at
70 ꢀC to give 15.1 g (24.7 mmol, 85.8%) dihydroergocristine.
M.p.: 180.7e181.6 ꢀC. Elemental composition: calc. for
2.3. Instrumental
The melting point was determined by the capillary tube method
using an automatic melting point meter (KSP I N, A. Krüss Optronic,
Hamburg, Germany). Elemental analysis was conducted using a
vario MACRO elemental analyzer (Elementar Analysensysteme
GmbH, Hanau, Germany). The NMR spectra were recorded on a
Bruker Avance 600 MHz (Bruker Corporation, Billerica, USA) with
the CD3OD peak as internal standard. Carbons were assigned based
on two dimensional NMR analysis (H,H-COSY, HSQC, HMQC). High-
resolution mass spectra were obtained with an Exactive Benchtop
Orbitrap™ mass spectrometer (Thermo Scientific™, Bremen, Ger-
many, USA). Infrared spectra were recorded on a Bruker Equinox 55
FT-IR spectrometer (Bruker Corporation, Billerica, USA) in the range
of 4.000e800 cmꢂ1. The single crystal X-ray data were collected at
room temperature using a Bruker AXS SMART diffractometer with
9´
8´
21´
18´
G
7´
6´
an APEX CCD area detector (Mo K
chronator,
were carried out using the Bruker AXS SAINT and SADABS packages.
The structures were solved by direct methods and refined against
F2 by full-matrix least squares calculation using SHELX97 [17].
a radiation, graphite mono-
¼ 0.71073 Å). Data reduction and adsorption correction
10´
N
F
O
l
20´
19´
22´
17´
11´
12´
H
13
H O
5´
N
12
14
15
1´
16´
O
4´
O
E
2´
3´
B
H
H
9
H
19
11
18
N
H
O
10
16
8
7
Table 1
13´
1 H N
A
C
D
6
Overview of solvents and masses of Dihydroergocristine used for crystallisation.
5
15´
14´
3
N
2
Solvent
mDHEC [mg]
VSolvent [mL]
4
Methanol
4.1
5.6
2.6
4.0
200
500
1000
200
17
Chloroform
Dichloromethane
Acetonitrile
Fig. 1. Chemical structure of DHEC with the numbering system used for
characterization.